Introduction: What This Guide Covers
For most people, the words “respiratory syncytial virus” — RSV — sound like a newborn baby’s illness. After all, infants now receive protective monoclonal antibodies in their first winter. But that picture is incomplete. In adults, especially past the age of 75 or in anyone living with chronic heart or lung disease, RSV can travel deep into the lower airways and trigger pneumonia, severe wheezing, and dangerous breathing failure. The virus behind the nursery sniffles can, in the wrong host, become a life-threatening event.
The numbers explain the silence around it. The Centers for Disease Control and Prevention (CDC) estimates that RSV causes roughly 60,000 to 160,000 hospitalizations and 6,000 to 10,000 deaths every year among Americans aged 65 and older — a toll comparable to seasonal influenza’s in this age group. Yet until 2023 there was no vaccine at all, and most adults have never been tested for RSV, so countless cases were simply labeled “a bad cold.”
That is changing fast: three adult RSV vaccines exist, eligibility has expanded to younger high-risk adults, and mature data shows they prevent roughly three-quarters of hospitalizations. This guide covers how the virus spreads, what it does inside your airways, the three vaccines and who should get one under the CDC’s February 2026 guidance, the symptom timeline with red flags, the tests that confirm it, treatment, recovery foods, and what to avoid — and why the 2026–27 season is different from every season before it.
Medically reviewed by Dr. Ata Ullah, MD (Medicine).
What Causes RSV: The Virus, How It Spreads, and Who Is Most at Risk
RSV is a single virus — a single-stranded RNA virus of the Pneumoviridae family — and it is the sole cause of every RSV infection. Almost every human being is infected by the age of two, and because natural immunity is incomplete and fades over time, reinfection happens throughout life. Adults are typically reinfected every few years, often so mildly that the episode passes unnoticed.
Transmission follows three familiar routes. First, respiratory droplets: coughing, sneezing, and even talking spray virus-laden droplets that land on the eyes, nose, or mouth of someone nearby. Second, contaminated surfaces: RSV survives for several hours on hard surfaces such as doorknobs and phones — touching one and then your face is a classic route. Third, close personal contact, such as kissing an infected child. People with RSV are usually contagious for 3 to 8 days; the immunocompromised can shed the virus for weeks. Grandparents frequently catch it from young grandchildren, in whom the infection is most intense and most heavily shed.
Severe adult disease concentrates in specific groups: adults 75 and older; people with COPD or asthma; those with chronic heart failure; people with diabetes; those with chronic kidney or liver disease; anyone immunocompromised by cancer treatment, organ transplantation, HIV, or long-term steroids; nursing-home residents; people with severe obesity; and frail older adults generally. For these groups, a routine upper-airway infection can descend into the lungs — which is why prevention is aimed squarely at them.
How RSV Attacks the Airways
Once RSV lands on the lining of your nose or throat, it does not simply sit on the surface. The virus carries a protein called the F (fusion) glycoprotein on its outer envelope. This protein latches onto airway epithelial cells and forces the viral envelope to fuse with the human cell membrane, pouring the virus’s genetic material inside. Infected cells then fuse with their neighbors into large multi-nucleated masses called syncytia — literally “cells fused together.” That fusion gave the virus its name: respiratory syncytial virus.
These fused, dying cells slough off into the airway. Dead cells, mucus, and inflammatory debris pile up while the virus damages the tiny cilia whose sweeping motion normally clears the airways. In the narrow small airways this debris acts like a partial plug: air gets in with effort but struggles to get out, producing wheeze and shortness of breath, while inflammation swells the airway walls and narrows the passage further. In mild adult infections the battle stays in the nose and throat; in severe ones it reaches the bronchioles and lung tissue, causing bronchiolitis-like illness and viral pneumonia.
Why do older adults suffer the severe form while healthy thirty-year-olds usually do not? With age, T-cell responses — the immune arm that hunts virus-infected cells — weaken, antibody memory fades, and viral clearance slows, giving the virus extra days to reach the lungs. Chronic heart and lung disease then shrink the body’s reserve: the same airway inflammation a young adult barely notices can tip a 78-year-old with heart failure or COPD into respiratory failure. That is why age 75-plus, more than any other single factor, predicts a severe course.
Prevention and the Three Adult Vaccines
The single biggest development in adult RSV prevention is that vaccines finally exist — three of them:
| Vaccine | Maker | Technology | Key facts |
|---|---|---|---|
| Arexvy | GSK | Protein subunit | The world’s first RSV vaccine (May 2023); stabilized F protein plus adjuvant. |
| Abrysvo | Pfizer | Protein subunit | Also FDA-approved for pregnant people at 32–36 weeks, protecting newborns via maternal antibodies. |
| mResvia | Moderna | mRNA | The same platform class behind the new mRNA flu vaccine — your own cells build the RSV F protein. |
Common side effects are familiar: a sore arm, fatigue, and headache for a day or two. Note that FDA labeling for two of the vaccines mentions a small possible increased risk of Guillain-Barré syndrome, a rare nerve disorder — the absolute risk is tiny, but discuss it with your doctor if you have a history of it. If you are nervous about getting shots together, our guide to flu shot side effects explains what is normal and what is not.
Here is the uncomfortable truth behind the 2026 season: as of February 22, 2026, only 43% of adults 75+ and 33% of high-risk adults 50–74 had ever received an RSV vaccine, per the American Lung Association (press release), with even lower rates among Hispanic and Latino adults. Vaccination can happen any time of year and in the same visit as flu and COVID-19 shots — getting it now, in October, means protection is in place before the winter peak.
One clarification: the monoclonal antibodies nirsevimab (Beyfortus), clesrovimab (Enflonsia), and palivizumab (Synagis) are for INFANTS, not adults. They are not vaccines and not an adult option. Beyond vaccination: wash hands for 20 seconds, mask in crowded indoor settings during peak season, ventilate rooms, stay home when sick, and disinfect high-touch surfaces regularly.
Symptoms, Timeline, and Red Flags
The incubation period is 2 to 8 days, typically 4 to 6 days. In adults the illness usually starts in the upper airways; healthy adults often stop at that stage, but in older adults and those with chronic illness the infection can keep moving downward:
| Phase | Timeframe | What you feel |
|---|---|---|
| Onset | Days 1–2 | Runny or stuffy nose, sneezing, sore throat, mild dry cough, low-grade fever, headache — easily mistaken for a cold. |
| Deepening | Days 3–5 | Cough becomes persistent, congestion thickens, fatigue grows; high-risk adults may start wheezing with chest tightness. |
| Decision point | Days 5–8 | Either steady improvement, or descent into the lower airways: worsening cough, shortness of breath, wheezing, chest discomfort, reduced stamina. |
| Recovery | Week 2+ | Most adults recover fully within 1–2 weeks, though a dry cough can linger; severe cases may need hospital oxygen in this window. |
Telling RSV apart from its winter cousins is difficult without a test, but patterns help:
| Feature | RSV | Common cold | Flu | COVID-19 |
|---|---|---|---|---|
| Onset | Gradual | Gradual | Abrupt | Gradual |
| Fever | Low-grade or none | Rare | High, common | Variable |
| Wheezing | Common in severe adult cases | Uncommon | Uncommon | Less typical |
| Body aches | Mild | Mild | Prominent | Moderate |
| Signature clue | Wheezing + prolonged cough in an older adult | Stays in the nose | Sudden high fever + aches | Shifting variants — see our guide to the new COVID variants for this season’s strains |
• Trouble breathing, rapid or labored breathing, or being unable to speak full sentences
• Bluish lips, face, or fingernails (low oxygen)
• Chest pain or pressure
• New confusion or unusual drowsiness
• Inability to keep fluids down, very dark urine, or dizziness on standing (dehydration)
• Fever returning or clear worsening after initial improvement
• A pulse-oximeter reading below 94% on room air
These can signal viral pneumonia or respiratory failure — never “wait and see” with breathing difficulty.
RSV in Babies and Children
This guide focuses on adults, but RSV is best known as a childhood virus: virtually every child has had it before turning two. In most children the illness is mild, yet it can turn dangerous for infants — RSV is the leading cause of bronchiolitis and pneumonia in children under one year old worldwide.
Symptoms in infants (can become severe)
- Irritability and poor feeding
- Lethargy or unusual sleepiness
- Pauses in breathing (apnoea) — especially in very young or premature babies
- Rapid, shallow breathing or flaring nostrils
- Wheezing or crackling sounds when breathing
- Bluish colour around the lips or fingernails
- Severe cough with thick mucus
Warning signs in a baby that need urgent care: difficulty breathing (ribs or neck visibly pulling in with each breath), pauses in breathing, blue-tinged skin or lips, dehydration (fewer wet nappies, no tears when crying), or extreme drowsiness. Do not wait — seek emergency care.
The Tests That Confirm RSV
Symptoms overlap heavily with flu, COVID-19, and colds, so a laboratory test is the only way to confirm RSV:
1. Multiplex PCR respiratory panel — the gold standard. Ordered for moderate-to-severe symptoms, high-risk patients, and admissions. One nasal/throat swab is checked for RSV RNA alongside influenza and SARS-CoV-2. Results: a positive confirms active infection; a negative on a good sample makes RSV unlikely. Turnaround: hours.
2. Rapid molecular (point-of-care NAAT) tests. Used in clinics and ERs for answers in 15–30 minutes. Results: highly reliable positives — ideal for fast triage of high-risk adults.
3. Rapid antigen tests. Quick swabs detecting viral proteins. Results — with a caution: less sensitive in adults because adults shed less virus. A positive is trustworthy, but a negative does not rule out RSV — high-risk patients should get PCR confirmation.
4. Pulse oximetry. The finger-clip measuring blood oxygen (SpO2), for anyone breathless or high-risk. Results: 95–100% normal; below 94% on room air warrants prompt medical advice; below 90% is an emergency.
5. Chest X-ray. Ordered for suspected pneumonia — persistent low oxygen, severe symptoms, abnormal lung sounds. Results: patchy or bilateral infiltrates suggest viral pneumonia; a clear film points to uncomplicated upper-airway disease.
6. Arterial blood gas (ABG). Reserved for severe hospitalized cases. Results: falling oxygen with rising carbon dioxide signals failing ventilation — a trigger for ICU-level support.
7. CBC and basic metabolic panel. For hospitalized or complicated cases. Results: rising white cells may hint at secondary bacterial infection; the metabolic panel reveals dehydration, kidney strain, or electrolyte shifts.
Treatment, and the Emergency Medicines Guide
The key fact: there is no approved RSV-specific antiviral drug for adults. Treatment is supportive — keeping the body oxygenated, hydrated, and comfortable while the immune system clears the virus. Mild cases need rest, fluids, and fever control at home; serious illness escalates to supplemental oxygen, IV fluids, and close monitoring.
Hospitalization is considered when oxygen stays low despite rest, the patient cannot stay hydrated, breathing visibly worsens, or major comorbidities make home monitoring unsafe. Ribavirin is sometimes mentioned online, but in practice it is used only in very limited settings — mainly severely immunocompromised patients — with weak evidence of benefit. Bronchodilators such as albuterol and systemic corticosteroids are occasionally tried for wheezing but have limited proven benefit in adult RSV. Antibiotics do not treat RSV at all; they are added only for confirmed secondary bacterial infection.
Escalation means the ICU: high-flow nasal oxygen, noninvasive ventilation (a mask assisting breathing), and, in respiratory failure, mechanical ventilation. Most healthy adults recover within one to two weeks; high-risk patients need closer monitoring because deterioration can be rapid.
Emergency Medicines Guide — Symptom → Medicine Class
What doctors and pharmacists commonly recommend for symptom relief — generic names only, and deliberately no dosage instructions: dosage must come from your doctor/pharmacist.
- Fever and body aches → antipyretic class (e.g., acetaminophen) — dosage must come from your doctor/pharmacist.
- Pain and inflammation → NSAID class (e.g., ibuprofen) — dosage must come from your doctor/pharmacist.
- Nasal congestion → decongestant class (e.g., pseudoephedrine) — dosage must come from your doctor/pharmacist.
- Dry, hacking cough → antitussive class (e.g., dextromethorphan) — dosage must come from your doctor/pharmacist.
- Chest mucus that will not clear → expectorant class (e.g., guaifenesin) — dosage must come from your doctor/pharmacist.
- Sneezing, runny nose, itchy eyes → antihistamine class (e.g., loratadine or cetirizine) — dosage must come from your doctor/pharmacist.
Foods That Support Recovery
Food will not kill the virus, but the right diet speeds recovery. Each recommendation below comes with its reason.
Hydrate aggressively. Water, clear broths, and oral rehydration drinks are the foundation: fever and mouth-breathing lose fluid fast, and hydrated mucus is thinner and easier to cough out. Pale-yellow urine is your guide.
Warm chicken or lentil soup. Steam loosens congestion, warm fluid soothes a raw throat, and the protein supplies amino acids needed to build antibodies and repair damaged airway cells — plus it is easy to swallow when the throat is sore.
Honey for cough (adults only). A spoonful in warm water or tea coats an irritated throat, and trials show it calms nighttime cough comparably to some over-the-counter suppressants. Never give honey to children under one year.
Vitamin C–rich foods. Citrus, bell peppers, and guava support epithelial barriers and immune-cell function. Regular servings through the illness beat megadoses.
Protein at every meal. Eggs, yogurt, fish, chicken, lentils, beans — immune cells turn over rapidly during infection, and rebuilding runs on dietary protein. Make each small meal count.
Zinc-containing foods. Meat, pumpkin seeds, and chickpeas provide zinc, a mineral involved in immune-cell development. Mild deficiency is common in older adults — exactly the group RSV hits hardest.
Soft foods when swallowing hurts. Oatmeal, mashed potatoes, smoothies, and bananas keep calories coming when a sore throat makes normal meals miserable. Eat small, frequent meals.
What to Avoid While You Recover
Alcohol. Dehydrates, fragments sleep — when immune repair peaks — and suppresses immune responses. Skip it until fully recovered.
Smoking and vaping. They paralyze and damage the cilia RSV has already injured and add fresh inflammation to swollen airways. Avoid both and keep the home smoke-free while anyone inside is ill.
Very sugary drinks. Sodas and sweetened juices spike and crash energy without replacing what illness takes, and excess sugar can worsen dehydration. Water and broth are better.
Dairy — an honest answer. No solid evidence says milk increases mucus production; that is largely myth. But many people genuinely feel dairy thickens throat secretions — if that is you, pause it a few days as a personal comfort call, not a medical rule.
Cold, dry air. Frigid dry air can trigger coughing fits in inflamed airways. A humidifier, or a warm scarf loosely over nose and mouth outdoors, keeps inhaled air friendlier.
Self-medicating with leftover antibiotics. RSV is viral; antibiotics cannot touch it, and unnecessary use breeds resistant bacteria. Take them only if a doctor diagnoses a bacterial complication.
Overusing decongestant sprays. Beyond the few days on the label, topical decongestants cause rebound congestion — worse stuffiness than you started with. Saline rinses are safer for longer use.
Frequently Asked Questions
Can adults get RSV?
Yes — adults are reinfected regularly. In healthy adults it usually feels like a cold, but it can be serious for those over 65 or with heart, lung, or immune conditions.
How long does RSV last?
Mild cases resolve in one to two weeks, though the cough can linger. Severe cases in infants may require hospitalisation.
Is there an RSV vaccine?
Yes — vaccines are now available for older adults and for pregnant women (to protect newborns), and preventive monoclonal antibody injections protect infants. Availability varies by country; ask your doctor.
A Final Word
RSV season is arriving — but this year, older adults are not defenseless. One vaccine dose, with real-world protection around 75% against hospitalization, can stand between you and a winter hospital stay. Whether you are 76 and healthy, 58 with COPD, or caring for aging parents, one conversation with your clinician this week can change your whole season. Rest well, hydrate, eat to recover — and never try to “tough out” breathing difficulty. Your lungs have carried you this far; this winter, give them the protection they deserve.
Medical Reviewer
Dr. Ata Ullah, MBBS, MD (Medicine) — Physician Consultant, Senior Medical Officer at DHQ Hospital, Layyah, Pakistan.
Motto: “Your Health, Our Responsibility.”
Online Consultation: Dr. Ata Ullah (MBBS, MD Medicine), Physician Consultant / Medical Specialist — WhatsApp: 0315 7148181 — Consultation Fees: $30

